Does precision phenotyping using clinical and biological data improve prognostic value compared to traditional risk models in patients with dilated cardiomyopathy?
Identification of three distinct DCM subtypes using clinical and biological data adds prognostic value to traditional risk models and may enable precision medicine.
Three reproducible, mechanistically distinct DCM subtypes were identified using widely available clinical and biological data, adding prognostic value to traditional risk models. They may improve patient selection for novel interventions, thereby enabling precision medicine.
Tayal et al. (Mon,) studied this question.